Cargando…

PPARα: A potential therapeutic target of cholestasis

The accumulation of bile acids in the liver leads to the development of cholestasis and hepatocyte injury. Nuclear receptors control the synthesis and transport of bile acids in the liver. Among them, the farnesoid X receptor (FXR) is the most common receptor studied in treating cholestasis. The act...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Xiaoyin, Zhang, Tong, Han, Han
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342652/ https://www.ncbi.nlm.nih.gov/pubmed/35924060 http://dx.doi.org/10.3389/fphar.2022.916866

Ejemplares similares

Mechanism of interventional effect and targets of Zhuyu pill in regulating and suppressing colitis and cholestasis
por: Yu, Han, et al.
Publicado: (2022)

Da-Chai-Hu-Tang Protects From Acute Intrahepatic Cholestasis by Inhibiting Hepatic Inflammation and Bile Accumulation via Activation of PPARα
por: Xu, Shihao, et al.
Publicado: (2022)

Emerging Therapeutic Role of PPAR–α in Cognition and Emotions
por: Nisbett, Khalin E., et al.
Publicado: (2018)

Involvement of oxidative species in cyclosporine-mediated cholestasis
por: Nsengimana, Bernard, et al.
Publicado: (2022)

Glycyrrhetinic Acid Protects α-Naphthylisothiocyanate- Induced Cholestasis Through Regulating Transporters, Inflammation and Apoptosis
por: Yan, Miao, et al.
Publicado: (2021)

The zhuyu pill relieves rat cholestasis by regulating the mRNA expression of lipid and bile metabolism associated genes
por: Han, Jun, et al.
Publicado: (2023)

Metabolomic Analysis Reveals the Therapeutic Effects of MBT1805, a Novel Pan-Peroxisome Proliferator-Activated Receptor Agonist, on α-Naphthylisothiocyanate-Induced Cholestasis in Mice
por: Wang, Chang, et al.
Publicado: (2021)

Neobavaisoflavone Induces Bilirubin Metabolizing Enzyme UGT1A1 via PPARα and PPARγ
por: Zhu, Ya-Di, et al.
Publicado: (2021)

Fenofibrate suppresses corneal neovascularization by regulating lipid metabolism through PPARα signaling pathway
por: Zhou, Tong, et al.
Publicado: (2022)

Pterostilbene Alleviates Cholestasis by Promoting SIRT1 Activity in Hepatocytes and Macrophages
por: Ma, Chuanrui, et al.
Publicado: (2021)

Efficacy of Zhuyu Pill Intervention in a Cholestasis Rat Model: Mutual Effects on Fecal Metabolism and Microbial Diversity
por: Yu, Han, et al.
Publicado: (2021)

The Pathological Mechanisms of Estrogen-Induced Cholestasis: Current Perspectives
por: Zu, Yue, et al.
Publicado: (2021)

Baicalin Protects Against 17α-Ethinylestradiol-Induced Cholestasis via the Sirtuin 1/Hepatic Nuclear Receptor-1α/Farnesoid X Receptor Pathway
por: Yang, Jinyu, et al.
Publicado: (2020)

Bawei Chenxiang Wan Ameliorates Cardiac Hypertrophy by Activating AMPK/PPAR-α Signaling Pathway Improving Energy Metabolism
por: Zhang, Xiaoying, et al.
Publicado: (2021)

Metabolomics Coupled with Multivariate Data and Pathway Analysis on Potential Biomarkers in Cholestasis and Intervention Effect of Paeonia lactiflora Pall.
por: Ma, Xiao, et al.
Publicado: (2016)

Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα
por: Sun, Ying, et al.
Publicado: (2018)

Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis
por: Xie, Shuying, et al.
Publicado: (2023)

SRT1720 Alleviates ANIT-Induced Cholestasis in a Mouse Model
por: Yu, Linxi, et al.
Publicado: (2017)

Paracrine Fibroblast Growth Factor 1 Functions as Potent Therapeutic Agent for Intrahepatic Cholestasis by Downregulating Synthesis of Bile Acid
por: Lin, Huan, et al.
Publicado: (2019)

Dioscin Protects ANIT-Induced Intrahepatic Cholestasis Through Regulating Transporters, Apoptosis and Oxidative Stress
por: Yao, Hong, et al.
Publicado: (2017)

Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy
por: Yu, Jing, et al.
Publicado: (2021)

Targeted bile acid profiles reveal the liver injury amelioration of Da-Chai-Hu decoction against ANIT- and BDL-induced cholestasis
por: Zhou, YueHua, et al.
Publicado: (2022)

Commentary: Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy
por: Liu, Zengying, et al.
Publicado: (2022)

Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration
por: Qiu, Fangfang, et al.
Publicado: (2017)

Yinchenhao Decoction Ameliorates Alpha-Naphthylisothiocyanate Induced Intrahepatic Cholestasis in Rats by Regulating Phase II Metabolic Enzymes and Transporters
por: Yi, Ya-Xiong, et al.
Publicado: (2018)

Gegen Qinlian Decoction Coordinately Regulates PPARγ and PPARα to Improve Glucose and Lipid Homeostasis in Diabetic Rats and Insulin Resistance 3T3-L1 Adipocytes
por: Tu, Jun, et al.
Publicado: (2020)

Paeoniflorin alleviates 17α-ethinylestradiol-induced cholestasis via the farnesoid X receptor-mediated bile acid homeostasis signaling pathway in rats
por: Wang, Rulin, et al.
Publicado: (2022)

Comparative Evidence for Intrahepatic Cholestasis of Pregnancy Treatment With Traditional Chinese Medicine Therapy: A Network Meta-Analysis
por: Jiang, Yinxiao, et al.
Publicado: (2021)

Mechanism of crocin I on ANIT-induced intrahepatic cholestasis by combined metabolomics and transcriptomics
por: Song, Dandan, et al.
Publicado: (2023)

Hepatoprotective agents in the management of intrahepatic cholestasis of pregnancy: current knowledge and prospects
por: Shan, Dan, et al.
Publicado: (2023)

Nerve growth factor upregulates sirtuin 1 expression in cholestasis: a potential therapeutic target
por: Tsai, Ming-Shian, et al.
Publicado: (2018)

The potential of natural products for targeting PPARα
por: Rigano, Daniela, et al.
Publicado: (2017)

Hippocampal PPARα Plays a Role in the Pharmacological Mechanism of Vortioxetine, a Multimodal-Acting Antidepressant
por: Wang, Yuan, et al.
Publicado: (2021)

Phytochemicals Mediate the Expression and Activity of OCTN2 as Activators of the PPARγ/RXRα Pathway
por: Luo, Jian, et al.
Publicado: (2016)

Dibutyltin Compounds Effects on PPARγ/RXRα Activity, Adipogenesis, and Inflammation in Mammalians Cells
por: Milton, Flora A., et al.
Publicado: (2017)

Bailing capsule (Cordyceps sinensis) ameliorates renal triglyceride accumulation through the PPARα pathway in diabetic rats
por: Zhang, Qian, et al.
Publicado: (2022)

Therapeutic Potential of Targeting ß-Arrestin
por: Bond, Richard A., et al.
Publicado: (2019)

PPARα Ameliorates Doxorubicin-Induced Cardiotoxicity by Reducing Mitochondria-Dependent Apoptosis via Regulating MEOX1
por: Wang, Wei, et al.
Publicado: (2020)

The IDI1/SREBP2 axis drives intrahepatic cholestasis and is a treatment target of San-Huang-Cai-Zhu formula identified by sequencing and experiments
por: Yan, Junbin, et al.
Publicado: (2023)

PG F(2α) Receptor: A Promising Therapeutic Target for Cardiovascular Disease
por: Zhang, Jian, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_fgte1ad6g2d48rnmv3qtsuratj